Artemis Investment Management’s Repligen RGEN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$16.6M Sell
121,727
-300,061
-71% -$36.9M 0.15% 138
2026
Q1
$49.7M Buy
421,788
+11,419
+3% +$1.6M 0.53% 74
2025
Q4
$67.2M Buy
410,369
+63,583
+18% +$9.96M 0.81% 42
2025
Q3
$46.4M Buy
346,786
+91,915
+36% +$11.2M 0.58% 65
2025
Q2
$31.7M Sell
254,871
-68,358
-21% -$8.7M 0.41% 85
2025
Q1
$41.1M Buy
323,229
+169,397
+110% +$26.1M 0.63% 59
2024
Q4
$22.1M Buy
153,832
+23,905
+18% +$3.43M 0.32% 95
2024
Q3
$19.3M Buy
129,927
+42,118
+48% +$6.04M 0.29% 102
2024
Q2
$11.1M Sell
87,809
-80,004
-48% -$12.5M 0.15% 132
2024
Q1
$30.9M Buy
167,813
+42,380
+34% +$8.07M 0.39% 80
2023
Q4
$22.6M Buy
+125,433
New +$19.5M 0.33% 89

Other funds holding RGEN

Artemis Investment Management's RGEN Position: Q2 2026 in Review

Artemis Investment Management reduced its Repligen (RGEN) stake by 71% in Q2 2026, selling an estimated $36.9M and leaving 121,727 shares worth $16.6M. The position accounts for 0.15% of the portfolio, ranked #138.

Artemis Investment Management first reported a position in RGEN in Q4 2023 and has held it in 11 quarters since. The position peaked at $67.2M in Q4 2025. 482 funds tracked by Wall St. Rank hold RGEN as of Q2 2026.

  • Artemis Investment Management held 121,727 shares of Repligen worth $16.6M as of Q2 2026.
  • Artemis Investment Management sold 300,061 Repligen shares in Q2 2026, an estimated $36.9M.
  • Repligen made up 0.15% of Artemis Investment Management's portfolio in Q2 2026, its #138 holding.
  • Artemis Investment Management first reported a position in Repligen in Q4 2023 and has held it in 11 quarters since.
  • Artemis Investment Management's Repligen position peaked at $67.2M in Q4 2025.
  • 482 funds tracked by Wall St. Rank held Repligen as of Q2 2026.

Based on Artemis Investment Management's 13F filing for Q2 2026, filed 23 Jul 2026.